Skip to content
November 13, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Surgery and Reconstruction
  • The Synergistic Future of Facial Rejuvenation: Redefining the Standard for Face and Neck Lifts
  • Breast Cancer Surgery and Reconstruction

The Synergistic Future of Facial Rejuvenation: Redefining the Standard for Face and Neck Lifts

Lina Irawan November 13, 2026 7 minutes read
the-synergistic-future-of-facial-rejuvenation-redefining-the-standard-for-face-and-neck-lifts

In the rapidly evolving landscape of aesthetic medicine, the traditional "gold standard" of facial rejuvenation—the surgical facelift—is undergoing a profound transformation. For decades, surgeons have relied on the mechanical repositioning of tissues to address the sagging and laxity associated with aging. However, a groundbreaking study published in the July issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), suggests that surgery alone is no longer the ceiling for patient outcomes.

By integrating surgical intervention with advanced plasma skin resurfacing and regenerative medicine, practitioners are now achieving what many previously considered impossible: a multi-dimensional correction of facial aging that treats the underlying muscle structure, the subcutaneous volume, and the skin surface simultaneously.


Main Facts: A Holistic Paradigm Shift

The study, led by Melinda Lacerna Kimbrell, MD, of LA Plastic Surgery in Bradenton, Florida, introduces a comprehensive protocol that challenges the compartmentalized approach to facial aging. Historically, surgeons often hesitated to combine deep-tissue surgery with aggressive skin resurfacing due to concerns regarding post-operative healing and potential complications. Dr. Kimbrell’s research provides clinical evidence that this apprehension may be outdated.

The study examined 96 patients who underwent a sophisticated "all-in-one" procedure, encompassing:

  • Surgical Repositioning: Traditional face and neck lifts to address gravity-induced laxity.
  • Volume Restoration: Full-face fat grafting to counteract the hollows associated with aging.
  • Surface Resurfacing: Deep plasma skin resurfacing to address sun damage, fine lines, and textural irregularities.
  • Regenerative Support: Topical applications, including nanofat cream and exosomes, to accelerate tissue healing and cellular repair.

The central thesis of the research is that facial aging is not a singular issue but a triad of structural sagging, volume depletion, and surface degradation. By addressing all three in a single operative session, surgeons can provide a more harmonious and youthful result than can be achieved by surgery alone.


Chronology: The Evolution of the Combined Protocol

To understand the significance of Dr. Kimbrell’s work, one must look at the progression of aesthetic surgery over the last twenty years.

The Era of "Surgery Only" (Early 2000s)

During this period, the focus was almost exclusively on the "pull." Surgeons concentrated on the SMAS (superficial musculoaponeurotic system) layer to lift sagging jowls and neck skin. While effective for structural contouring, patients often emerged from these procedures with a "stretched" appearance—the underlying skin quality remained weathered, wrinkled, and sun-damaged.

The Rise of Volume (2010s)

The middle of the last decade saw the widespread adoption of fat grafting and dermal fillers. Surgeons recognized that "lifting" a deflated face only resulted in a tight, flat appearance. The integration of autologous fat grafting became a staple, adding a natural "plumpness" that mimics the facial structure of youth.

The Current "Synergistic" Era (2024 and Beyond)

The current research represents the culmination of these trends. By adding plasma skin resurfacing and regenerative biology (exosomes and nanofat) to the surgical plan, the recovery process has been redefined. Where previously a patient might undergo a facelift and then seek laser resurfacing months or years later, the modern approach consolidates these efforts. The chronology of the procedure is now streamlined: the surgery provides the foundation, the fat provides the volume, and the plasma resurfacing provides the "finish," all supported by the regenerative power of exosomes.


Supporting Data: Quantifying the Youthful Result

The strength of the study lies in its objective measurement of results. Utilizing advanced facial scanning technology, Dr. Kimbrell’s team evaluated skin age, elasticity, and wrinkle depth before and after the combined procedures. The findings were statistically significant:

  • Skin Age: Patients demonstrated an average improvement of four years in their biological skin age.
  • Elasticity: A nearly 10-year improvement in skin elasticity was observed, suggesting that the combination of plasma resurfacing and regenerative treatments significantly boosts collagen and elastin production.
  • Wrinkle Reduction: The data showed a seven-year improvement in the appearance of facial wrinkles.

These metrics are critical because they move the conversation beyond subjective "patient satisfaction" and into the realm of measurable, clinical improvement. The study also highlighted the safety profile of the combined approach. Despite the complexity of the procedures, the cohort of 96 patients did not experience an increased rate of complications, debunking the long-held fear that combining resurfacing with lifting would lead to necrosis or delayed wound healing.


Official Responses and Clinical Perspectives

Dr. Melinda Lacerna Kimbrell, the lead author of the study, emphasizes that the true secret to this safety and efficacy lies in the regenerative component.

"There is something synergistic when we use them at the same time," Dr. Kimbrell notes. "When we are healing both underneath the skin with the facelift and on top of the skin from the resurfacing, the results are exponentially better. Facelifts alone do not address skin aging, and they certainly do not address volume loss. You need a multi-modal approach to get a natural, rejuvenated look."

A key element of her methodology is the customization of the resurfacing device. Because skin tone and ethnicity play a major role in how patients react to energy-based devices, Dr. Kimbrell emphasizes the use of either low-intensity helium or nitrogen plasma devices. This customization ensures that the resurfacing is effective for a broad range of skin types, significantly reducing the risk of hyperpigmentation or scarring—common concerns with older laser technologies.

"I would not do this without regenerative medicine," Dr. Kimbrell stresses. "The inclusion of fat grafting, nanofat cream, and exosomes is the ‘glue’ that allows these aggressive treatments to work in tandem without compromising the patient’s healing journey."


Implications: The Future of Aesthetic Consultations

The implications of this study for both patients and plastic surgeons are profound.

For the Patient

The most immediate benefit is the consolidation of the surgical journey. Combining procedures reduces the total time under anesthesia—a significant factor for patient safety—and streamlines the recovery period. Instead of facing multiple surgeries, months of healing, and separate billing cycles, patients can achieve a comprehensive transformation in one go.

For the Surgeon

The study sets a new benchmark for what patients should expect from a "facelift." As awareness of this synergistic approach grows, surgeons may find themselves pressured to expand their toolkits beyond traditional excision. The incorporation of regenerative medicine and energy-based resurfacing will likely become a mandatory skill set for the next generation of plastic surgeons.

The Path Forward

While the results are compelling, the research community is already looking toward the next horizon. The study highlights the need for further exploration into newer FDA-approved "cool" plasma devices, which may offer even greater safety margins for diverse skin types. Additionally, longitudinal studies measuring long-term patient satisfaction—specifically how these patients feel about their aesthetic results five to ten years post-operation—will be vital in validating this protocol as the new standard of care.

Ultimately, Dr. Kimbrell’s study confirms that the future of facial rejuvenation is not about choosing between surgery or skin treatments; it is about the intelligent, synchronized marriage of both. By looking at the face as a complex ecosystem of bone, muscle, fat, and skin, surgeons can finally offer a solution that is as comprehensive as the aging process itself.


For those interested in the technical details of the study, the full article, "Taking Face Lifts to the Next Level: Case Series Reflecting the Safety and Efficacy of Plasma Resurfacing with Face and Neck Lifts," can be accessed via the official Plastic and Reconstructive Surgery journal portal.

About the Author

Lina Irawan

Author

View All Posts

Post navigation

Previous: Biotech Roundup: Novo Nordisk Targets Sickle Cell Dominance as Industry Innovation Accelerates

Related Stories

optimizing-recovery-the-critical-role-of-nutrition-in-post-weight-loss-body-contouring-1
  • Breast Cancer Surgery and Reconstruction

Optimizing Recovery: The Critical Role of Nutrition in Post-Weight Loss Body Contouring

Asep Darmawan November 13, 2026
the-new-gateway-how-advanced-practice-providers-are-transforming-the-body-contouring-journey
  • Breast Cancer Surgery and Reconstruction

The New Gateway: How Advanced Practice Providers Are Transforming the Body Contouring Journey

Layla Zulfa November 12, 2026
the-evolution-of-aesthetic-medicine-2025-asps-report-reveals-shift-toward-authentic-restoration-1
  • Breast Cancer Surgery and Reconstruction

The Evolution of Aesthetic Medicine: 2025 ASPS Report Reveals Shift Toward “Authentic Restoration”

Ali Ikhwan November 12, 2026

Recent Posts

  • The Synergistic Future of Facial Rejuvenation: Redefining the Standard for Face and Neck Lifts
  • Biotech Roundup: Novo Nordisk Targets Sickle Cell Dominance as Industry Innovation Accelerates
  • A New Dawn for Childhood Cancer Survivors: St. Jude Unlocks Genetic Keys to Secondary Cancer Risk
  • Navigating the Clinical Frontier: Centessa Expert Advises Biotechs on Strategic CRO Partnerships
  • A Mother’s Legacy, a Daughter’s Resolve: Finding Strength and Hope in the Fight Against Breast Cancer

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-synergistic-future-of-facial-rejuvenation-redefining-the-standard-for-face-and-neck-lifts
  • Breast Cancer Surgery and Reconstruction

The Synergistic Future of Facial Rejuvenation: Redefining the Standard for Face and Neck Lifts

Lina Irawan November 13, 2026
biotech-roundup-novo-nordisk-targets-sickle-cell-dominance-as-industry-innovation-accelerates
  • Chemotherapy and Targeted Therapy

Biotech Roundup: Novo Nordisk Targets Sickle Cell Dominance as Industry Innovation Accelerates

Ammar Sabilarrohman November 13, 2026
a-new-dawn-for-childhood-cancer-survivors-st-jude-unlocks-genetic-keys-to-secondary-cancer-risk
  • Medical Research and Clinical Trials

A New Dawn for Childhood Cancer Survivors: St. Jude Unlocks Genetic Keys to Secondary Cancer Risk

Neng Nana November 13, 2026
navigating-the-clinical-frontier-centessa-expert-advises-biotechs-on-strategic-cro-partnerships
  • Medical Research and Clinical Trials

Navigating the Clinical Frontier: Centessa Expert Advises Biotechs on Strategic CRO Partnerships

Azzam Bilal Chamdy November 13, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.